Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | hypocretin (orexin) receptor 2 | Starlite/ChEMBL | References |
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled | Starlite/ChEMBL | References |
Homo sapiens | hypocretin (orexin) receptor 1 | Starlite/ChEMBL | References |
Homo sapiens | dopamine receptor D3 | Starlite/ChEMBL | References |
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled | Starlite/ChEMBL | References |
Rattus norvegicus | Serotonin 1b (5-HT1b) receptor | Starlite/ChEMBL | References |
Homo sapiens | potassium voltage-gated channel, subfamily H (eag-related), member 2 | Starlite/ChEMBL | References |
Homo sapiens | opioid receptor, mu 1 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | neuropeptide receptor A26 | 0.0019 | 0.0027 | 0.0088 |
Echinococcus granulosus | neuropeptide FF receptor 2 | 0.0019 | 0.0027 | 0.0086 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Loa Loa (eye worm) | hypothetical protein | 0.0376 | 0.1387 | 0.1385 |
Schistosoma mansoni | rhodopsin-like orphan GPCR | 0.0019 | 0.0027 | 0.0027 |
Echinococcus multilocularis | glycerol 3 phosphate dehydrogenase | 0.022 | 0.0792 | 0.2532 |
Echinococcus granulosus | rhodopsin orphan GPCR | 0.0019 | 0.0027 | 0.0086 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0137 | 0.0134 |
Entamoeba histolytica | NAD(FAD)-dependent dehydrogenase, putative | 0.022 | 0.0792 | 1 |
Trypanosoma cruzi | glycerol-3-phosphate dehydrogenase, putative | 0.022 | 0.0792 | 1 |
Loa Loa (eye worm) | voltage and ligand gated potassium channel | 0.0045 | 0.0124 | 0.0122 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Echinococcus multilocularis | G protein coupled 5 hydroxytryptamine receptor | 0.0019 | 0.0027 | 0.0088 |
Echinococcus multilocularis | neuropeptide FF receptor 2 | 0.0019 | 0.0027 | 0.0088 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0102 | 0.0099 |
Leishmania major | hypothetical protein, conserved | 0.022 | 0.0792 | 1 |
Echinococcus multilocularis | neuropeptide receptor | 0.0019 | 0.0027 | 0.0088 |
Echinococcus multilocularis | voltage gated potassium channel | 0.0013 | 0.0004 | 0.0012 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Loa Loa (eye worm) | hypothetical protein | 0.022 | 0.0792 | 0.0789 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Brugia malayi | G-protein coupled receptor | 0.0019 | 0.0027 | 0.0171 |
Echinococcus multilocularis | FAD dependent oxidoreductase domain containing protein | 0.022 | 0.0792 | 0.2532 |
Schistosoma mansoni | peptide (FMRFamide/somatostatin)-like receptor | 0.0019 | 0.0027 | 0.0027 |
Brugia malayi | GnHR receptor homolog | 0.0019 | 0.0027 | 0.0171 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0027 | 0.0027 |
Schistosoma mansoni | alpha-1 adrenergic receptor | 0.0019 | 0.0027 | 0.0027 |
Echinococcus granulosus | raf serine:threonine protein kinase | 0.0222 | 0.0801 | 0.2504 |
Schistosoma mansoni | ancient conserved domain protein 2 (cyclin m2) | 0.0019 | 0.0027 | 0.0027 |
Schistosoma mansoni | NAD dehydrogenase | 0.022 | 0.0792 | 0.0792 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0027 | 0.0027 |
Mycobacterium ulcerans | D-amino acid oxidase Aao | 0.2638 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Brugia malayi | Serotonin/octopamine receptor family protein 7 | 0.0376 | 0.1387 | 1 |
Echinococcus multilocularis | tm gpcr rhodopsin gpcr rhodopsin superfamily | 0.0019 | 0.0027 | 0.0088 |
Schistosoma mansoni | rhodopsin-like orphan GPCR | 0.0019 | 0.0027 | 0.0027 |
Schistosoma mansoni | peptide (allatostatin)-like receptor | 0.0019 | 0.0027 | 0.0027 |
Brugia malayi | putative neuropeptide receptor | 0.0019 | 0.0027 | 0.0171 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0021 | 0.0036 | 0.0112 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0027 | 0.0171 |
Loa Loa (eye worm) | neuropeptide F receptor | 0.0019 | 0.0027 | 0.0025 |
Echinococcus multilocularis | biogenic amine (5HT) receptor | 0.0019 | 0.0027 | 0.0088 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Mycobacterium ulcerans | glycerol-3-phosphate dehydrogenase | 0.022 | 0.0792 | 0.0759 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Schistosoma mansoni | neuropeptide f receptor 76f | 0.0019 | 0.0027 | 0.0027 |
Chlamydia trachomatis | D-amino acid dehydrogenase | 0.022 | 0.0792 | 0.5 |
Brugia malayi | Dopamine receptor protein 2 | 0.0019 | 0.0027 | 0.0171 |
Echinococcus granulosus | rhodopsin orphan GPCR | 0.0019 | 0.0027 | 0.0086 |
Echinococcus granulosus | neuropeptide Y receptor | 0.0019 | 0.0027 | 0.0086 |
Echinococcus multilocularis | g protein coupled receptor | 0.0019 | 0.0027 | 0.0088 |
Schistosoma mansoni | rhodopsin-like orphan GPCR | 0.0019 | 0.0027 | 0.0027 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.0019 | 0.0027 | 0.0027 |
Schistosoma mansoni | myosin xvIII | 0.0019 | 0.0027 | 0.0027 |
Brugia malayi | Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog | 0.0045 | 0.0124 | 0.0871 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0021 | 0.0036 | 0.0033 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Echinococcus granulosus | alpha 1A adrenergic receptor | 0.0019 | 0.0027 | 0.0086 |
Schistosoma mansoni | fad oxidoreductase | 0.022 | 0.0792 | 0.0792 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Leishmania major | hypothetical protein, conserved | 0.022 | 0.0792 | 1 |
Echinococcus granulosus | neuropeptides capa receptor | 0.0019 | 0.0027 | 0.0086 |
Echinococcus multilocularis | pyroglutamylated rfamide peptide receptor | 0.0019 | 0.0027 | 0.0088 |
Trypanosoma brucei | glycerol-3-phosphate dehydrogenase (FAD-dependent), putative | 0.022 | 0.0792 | 1 |
Brugia malayi | putative neuropeptide receptor NPR1 | 0.0019 | 0.0027 | 0.0171 |
Echinococcus multilocularis | neuropeptide Y receptor | 0.0019 | 0.0027 | 0.0088 |
Schistosoma mansoni | neuropeptide receptor | 0.0019 | 0.0027 | 0.0027 |
Brugia malayi | Unidentified vitellogenin-linked transcript protein 6, putative | 0.0019 | 0.0027 | 0.0171 |
Echinococcus multilocularis | tm gpcr rhodopsin gpcr rhodopsin superfamily | 0.0019 | 0.0027 | 0.0088 |
Brugia malayi | G protein-coupled receptor F59B2.13 | 0.0019 | 0.0027 | 0.0171 |
Echinococcus granulosus | neurotracting:lsamp:neurotrimin:obcam | 0.0013 | 0.0003 | 0.0008 |
Echinococcus multilocularis | rhodopsin orphan GPCR | 0.0019 | 0.0027 | 0.0088 |
Echinococcus multilocularis | orexin receptor type 2 | 0.0019 | 0.0027 | 0.0088 |
Schistosoma mansoni | rhodopsin-like orphan GPCR | 0.0019 | 0.0027 | 0.0027 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0027 | 0.0027 |
Schistosoma mansoni | amine GPCR | 0.0019 | 0.0027 | 0.0027 |
Echinococcus multilocularis | rhodopsin orphan GPCR | 0.0019 | 0.0027 | 0.0088 |
Echinococcus granulosus | roundabout 2 | 0.0015 | 0.0012 | 0.0037 |
Schistosoma mansoni | opsin-like receptor | 0.0019 | 0.0027 | 0.0027 |
Trypanosoma brucei | FAD dependent oxidoreductase, putative | 0.022 | 0.0792 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Echinococcus multilocularis | raf serine:threonine protein kinase | 0.0222 | 0.0801 | 0.2562 |
Brugia malayi | G protein-coupled receptor | 0.0019 | 0.0027 | 0.0171 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Echinococcus multilocularis | protein patched | 0.0048 | 0.0137 | 0.0438 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0027 | 0.0171 |
Loa Loa (eye worm) | hypothetical protein | 0.022 | 0.0792 | 0.0789 |
Echinococcus granulosus | biogenic amine 5HT receptor | 0.0166 | 0.0587 | 0.1835 |
Schistosoma mansoni | ATP:guanidino kinase (Smc74) | 0.022 | 0.0792 | 0.0792 |
Loa Loa (eye worm) | hypothetical protein | 0.022 | 0.0792 | 0.0789 |
Echinococcus granulosus | fmrfamide receptor | 0.0019 | 0.0027 | 0.0086 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Onchocerca volvulus | Tyrosine kinase homolog | 0.0145 | 0.0508 | 0.6293 |
Schistosoma mansoni | biogenic amine receptor | 0.0019 | 0.0027 | 0.0027 |
Loa Loa (eye worm) | G-protein-linked acetylcholine receptor protein 2 | 0.0019 | 0.0027 | 0.0025 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0049 | 0.014 | 0.014 |
Toxoplasma gondii | FAD-dependent glycerol-3-phosphate dehydrogenase | 0.022 | 0.0792 | 1 |
Schistosoma mansoni | cell adhesion molecule | 0.0013 | 0.0003 | 0.0003 |
Echinococcus granulosus | g protein linked acetylcholine receptor gar 2a | 0.0019 | 0.0027 | 0.0086 |
Brugia malayi | Dopamine receptor protein 1 | 0.0019 | 0.0027 | 0.0171 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0104 | 0.0349 | 0.1092 |
Schistosoma mansoni | niemann-pick C1 (NPC1) | 0.0113 | 0.0386 | 0.0386 |
Echinococcus multilocularis | G-protein coupled receptor, putative | 0.0019 | 0.0027 | 0.0088 |
Echinococcus granulosus | thyrotropin releasing hormone receptor | 0.0019 | 0.0027 | 0.0086 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0012 | 0.0009 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0042 | 0.0113 | 0.7633 |
Schistosoma mansoni | histamine h1 receptor | 0.0019 | 0.0027 | 0.0027 |
Onchocerca volvulus | Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial homolog | 0.022 | 0.0792 | 1 |
Brugia malayi | cDNA sequence BC016226 | 0.022 | 0.0792 | 0.5697 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0045 | 0.0124 | 0.0397 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0027 | 0.0171 |
Schistosoma mansoni | hypothetical protein | 0.0046 | 0.013 | 0.013 |
Schistosoma mansoni | rhodopsin-like orphan GPCR | 0.0019 | 0.0027 | 0.0027 |
Echinococcus granulosus | voltage gated potassium channel | 0.0013 | 0.0004 | 0.0011 |
Loa Loa (eye worm) | melatonin receptor type 1A | 0.0019 | 0.0027 | 0.0025 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Echinococcus granulosus | pyroglutamylated rfamide peptide receptor | 0.0019 | 0.0027 | 0.0086 |
Brugia malayi | neuropeptide F receptor | 0.0019 | 0.0027 | 0.0171 |
Echinococcus multilocularis | G protein coupled receptor 139 | 0.0143 | 0.0497 | 0.1591 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0013 | 0.0004 | 0.0004 |
Echinococcus granulosus | orexin receptor type 2 | 0.0019 | 0.0027 | 0.0086 |
Brugia malayi | RE15519p | 0.0019 | 0.0027 | 0.0171 |
Echinococcus granulosus | tm gpcr rhodopsin | 0.0019 | 0.0027 | 0.0086 |
Plasmodium falciparum | FAD-dependent glycerol-3-phosphate dehydrogenase, putative | 0.022 | 0.0792 | 1 |
Echinococcus granulosus | rhodopsin orphan GPCR | 0.0019 | 0.0027 | 0.0086 |
Loa Loa (eye worm) | gonadotropin-releasing hormone receptor 2 | 0.0019 | 0.0027 | 0.0025 |
Toxoplasma gondii | hypothetical protein | 0.022 | 0.0792 | 1 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0013 | 0.0004 | 0.0012 |
Echinococcus multilocularis | protein dispatched 1 | 0.0055 | 0.0163 | 0.052 |
Loa Loa (eye worm) | TYRA-2 protein | 0.0019 | 0.0027 | 0.0025 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Echinococcus multilocularis | tm gpcr rhodopsin gpcr rhodopsin superfamily | 0.0019 | 0.0027 | 0.0088 |
Brugia malayi | follicle stimulating hormone receptor | 0.0019 | 0.0027 | 0.0171 |
Echinococcus multilocularis | g-protein coupled receptor | 0.0019 | 0.0027 | 0.0088 |
Schistosoma mansoni | patched 1 | 0.0048 | 0.0137 | 0.0137 |
Trypanosoma cruzi | Present in the outer mitochondrial membrane proteome 20 | 0.022 | 0.0792 | 1 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0027 | 0.0171 |
Echinococcus granulosus | allatostatin A receptor | 0.0019 | 0.0027 | 0.0086 |
Echinococcus multilocularis | neuropeptide s receptor | 0.0019 | 0.0027 | 0.0088 |
Echinococcus granulosus | peptide allatostatin:somatostatin | 0.0019 | 0.0027 | 0.0086 |
Schistosoma mansoni | biogenic amine receptor | 0.0019 | 0.0027 | 0.0027 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Schistosoma mansoni | glycerol-3-phosphate dehydrogenase | 0.022 | 0.0792 | 0.0792 |
Mycobacterium ulcerans | glycerol-3-phosphate dehydrogenase GlpD2 | 0.022 | 0.0792 | 0.0759 |
Echinococcus multilocularis | sterol regulatory element binding protein | 0.0048 | 0.0137 | 0.0438 |
Echinococcus granulosus | Niemann Pick C1 protein | 0.0112 | 0.038 | 0.1186 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0104 | 0.0349 | 0.0349 |
Echinococcus granulosus | hypothetical protein | 0.0852 | 0.32 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Loa Loa (eye worm) | abnormal chemotaxis protein 14 | 0.0048 | 0.0137 | 0.0134 |
Schistosoma mansoni | ap endonuclease | 0.0021 | 0.0036 | 0.0036 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0027 | 0.0171 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0104 | 0.0349 | 0.2499 |
Onchocerca volvulus | 0.0141 | 0.0492 | 0.6075 | |
Echinococcus granulosus | sex peptide receptor | 0.0019 | 0.0027 | 0.0086 |
Trypanosoma cruzi | FAD dependent oxidoreductase, putative | 0.022 | 0.0792 | 1 |
Schistosoma mansoni | biogenic amine (dopamine) receptor | 0.0019 | 0.0027 | 0.0027 |
Echinococcus multilocularis | somatostatin receptor | 0.0019 | 0.0027 | 0.0088 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0021 | 0.0036 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Echinococcus multilocularis | tachykinin peptides receptor 99D | 0.0019 | 0.0027 | 0.0088 |
Schistosoma mansoni | neuropeptide F-like receptor | 0.0019 | 0.0027 | 0.0027 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.0166 | 0.0587 | 0.0587 |
Brugia malayi | CHE-14 protein | 0.0048 | 0.0137 | 0.0963 |
Loa Loa (eye worm) | glycerol-3-phosphate dehydrogenase | 0.022 | 0.0792 | 0.0789 |
Schistosoma mansoni | d-amino acid oxidase | 0.2638 | 1 | 1 |
Echinococcus granulosus | neuropeptides capa receptor | 0.0019 | 0.0027 | 0.0086 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.016 | 0.0562 | 0.1797 |
Echinococcus granulosus | tachykinin peptides receptor 99D | 0.0019 | 0.0027 | 0.0086 |
Echinococcus granulosus | neuropeptide receptor A26 | 0.0019 | 0.0027 | 0.0086 |
Schistosoma mansoni | amine GPCR | 0.0019 | 0.0027 | 0.0027 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0013 | 0.0004 | 0.0011 |
Echinococcus granulosus | tm gpcr rhodopsin | 0.0019 | 0.0027 | 0.0086 |
Schistosoma mansoni | neuropeptide receptor | 0.0143 | 0.0497 | 0.0497 |
Entamoeba histolytica | anaerobic glycerol-3-phosphate dehydrogenase subunit A, putative | 0.022 | 0.0792 | 1 |
Schistosoma mansoni | neuropeptide receptor | 0.0019 | 0.0027 | 0.0027 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0156 | 0.0547 | 0.0545 |
Echinococcus granulosus | tm gpcr rhodopsin | 0.0019 | 0.0027 | 0.0086 |
Echinococcus multilocularis | g protein linked acetylcholine receptor gar 2a | 0.0019 | 0.0027 | 0.0088 |
Loa Loa (eye worm) | hypothetical protein | 0.0166 | 0.0587 | 0.0585 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0012 | 0.0009 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0027 | 0.0171 |
Schistosoma mansoni | biogenic amine (octopamine/dopamine) receptor | 0.0376 | 0.1387 | 0.1387 |
Echinococcus granulosus | g protein coupled receptor | 0.0019 | 0.0027 | 0.0086 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Echinococcus multilocularis | Niemann Pick C1 protein | 0.0112 | 0.038 | 0.1214 |
Loa Loa (eye worm) | TKL/RAF/RAF protein kinase | 0.0126 | 0.0436 | 0.0434 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0049 | 0.014 | 0.014 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0027 | 0.0171 |
Loa Loa (eye worm) | raf kinase | 0.022 | 0.0794 | 0.0791 |
Schistosoma mansoni | hypothetical protein | 0.0046 | 0.013 | 0.013 |
Schistosoma mansoni | histamine-responsive GPCR (AAF21638) | 0.0019 | 0.0027 | 0.0027 |
Schistosoma mansoni | hypothetical protein | 0.0046 | 0.013 | 0.013 |
Schistosoma mansoni | amine GPCR | 0.0019 | 0.0027 | 0.0027 |
Echinococcus multilocularis | growth hormone secretagogue receptor type 1 | 0.0019 | 0.0027 | 0.0088 |
Echinococcus granulosus | sterol regulatory element binding protein | 0.0048 | 0.0137 | 0.0428 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Onchocerca volvulus | Putative fad oxidoreductase | 0.022 | 0.0792 | 1 |
Trypanosoma brucei | glycerol-3-phosphate dehydrogenase (FAD-dependent), mitochondrial | 0.022 | 0.0792 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0104 | 0.0349 | 0.0349 |
Schistosoma mansoni | neuropeptide F-like receptor | 0.0019 | 0.0027 | 0.0027 |
Trypanosoma cruzi | glycerol-3-phosphate dehydrogenase (FAD-dependent), putative | 0.022 | 0.0792 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0104 | 0.0349 | 0.0349 |
Brugia malayi | sulfakinin receptor protein | 0.0019 | 0.0027 | 0.0171 |
Loa Loa (eye worm) | hypothetical protein | 0.0376 | 0.1387 | 0.1385 |
Echinococcus granulosus | neuropeptide receptor | 0.0019 | 0.0027 | 0.0086 |
Schistosoma mansoni | opsin-like receptor | 0.0019 | 0.0027 | 0.0027 |
Brugia malayi | ORL1-like opioid receptor | 0.0019 | 0.0027 | 0.0171 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0042 | 0.0113 | 0.7633 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0021 | 0.0036 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0104 | 0.0349 | 0.1117 |
Echinococcus multilocularis | thyrotropin releasing hormone receptor | 0.0019 | 0.0027 | 0.0088 |
Echinococcus granulosus | serotonin receptor | 0.0019 | 0.0027 | 0.0086 |
Schistosoma mansoni | amine GPCR | 0.0019 | 0.0027 | 0.0027 |
Echinococcus granulosus | neuropeptide Y receptor | 0.0019 | 0.0027 | 0.0086 |
Mycobacterium ulcerans | D-amino acid oxidase Aao | 0.022 | 0.0792 | 0.0759 |
Mycobacterium tuberculosis | Probable D-amino acid oxidase Aao | 0.2418 | 0.9163 | 1 |
Brugia malayi | Tachykinin-like peptides receptor 99D | 0.0019 | 0.0027 | 0.0171 |
Brugia malayi | dimethylglycine dehydrogenase, mitochondrial precursor, putative | 0.022 | 0.0792 | 0.5697 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0027 | 0.0171 |
Schistosoma mansoni | peptide (allatostatin/somatostatin)-like receptor | 0.0019 | 0.0027 | 0.0027 |
Echinococcus granulosus | g protein coupled receptor | 0.0019 | 0.0027 | 0.0086 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0156 | 0.0547 | 0.3929 |
Brugia malayi | larval opioid receptor | 0.0019 | 0.0027 | 0.0171 |
Echinococcus granulosus | G protein coupled receptor 139 | 0.0019 | 0.0027 | 0.0086 |
Brugia malayi | Melatonin receptor type 1A | 0.0019 | 0.0027 | 0.0171 |
Echinococcus multilocularis | rhodopsin orphan GPCR | 0.0019 | 0.0027 | 0.0088 |
Schistosoma mansoni | peptide (FMRFamide/somatostatin)-like receptor | 0.0019 | 0.0027 | 0.0027 |
Brugia malayi | gonadotropin-releasing hormone receptor 2 | 0.0019 | 0.0027 | 0.0171 |
Schistosoma mansoni | muscarinic acetylcholine (GAR) receptor | 0.0019 | 0.0027 | 0.0027 |
Brugia malayi | pyruvate dehydrogenase phosphatase regulatory subunit precursor | 0.022 | 0.0792 | 0.5697 |
Loa Loa (eye worm) | hypothetical protein | 0.0166 | 0.0587 | 0.0585 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Echinococcus multilocularis | peptide (allatostatin:somatostatin) | 0.0019 | 0.0027 | 0.0088 |
Echinococcus granulosus | g protein linked acetylcholine receptor gar 2a | 0.0019 | 0.0027 | 0.0086 |
Brugia malayi | G-protein-linked acetylcholine receptor protein 2, putative | 0.0019 | 0.0027 | 0.0171 |
Brugia malayi | RE18450p | 0.022 | 0.0792 | 0.5697 |
Loa Loa (eye worm) | hypothetical protein | 0.0112 | 0.038 | 0.0377 |
Brugia malayi | Serotonin receptor | 0.0019 | 0.0027 | 0.0171 |
Echinococcus granulosus | 7tm_1 domain containing protein | 0.0019 | 0.0027 | 0.0086 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Echinococcus multilocularis | rhodopsin orphan GPCR | 0.0019 | 0.0027 | 0.0088 |
Plasmodium vivax | FAD-dependent glycerol-3-phosphate dehydrogenase, putative | 0.022 | 0.0792 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0104 | 0.0349 | 0.0347 |
Schistosoma mansoni | adenoreceptor | 0.0019 | 0.0027 | 0.0027 |
Echinococcus granulosus | Protein patched homolog 1 | 0.0048 | 0.0137 | 0.0428 |
Brugia malayi | G-protein coupled receptor | 0.0019 | 0.0027 | 0.0171 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Echinococcus multilocularis | roundabout 2 | 0.0015 | 0.0012 | 0.0038 |
Echinococcus multilocularis | conserved hypothetical protein | 0.0833 | 0.3127 | 1 |
Schistosoma mansoni | growth hormone secretagogue receptor | 0.0019 | 0.0027 | 0.0027 |
Echinococcus granulosus | neuropeptide receptor | 0.0143 | 0.0497 | 0.1554 |
Echinococcus granulosus | rhodopsin orphan GPCR | 0.0019 | 0.0027 | 0.0086 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0104 | 0.0349 | 0.1092 |
Brugia malayi | Serotonin receptor | 0.0019 | 0.0027 | 0.0171 |
Trypanosoma cruzi | glycerol-3-phosphate dehydrogenase (FAD-dependent), putative | 0.022 | 0.0792 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0048 | 0.0137 | 1 |
Echinococcus multilocularis | fmrfamide receptor | 0.0019 | 0.0027 | 0.0088 |
Echinococcus multilocularis | rhodopsin orphan GPCR | 0.0019 | 0.0027 | 0.0088 |
Loa Loa (eye worm) | hypothetical protein | 0.0013 | 0.0004 | 0.0001 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0104 | 0.0349 | 0.1117 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0027 | 0.0171 |
Echinococcus multilocularis | alpha 1A adrenergic receptor | 0.0019 | 0.0027 | 0.0088 |
Trypanosoma brucei | electron transfer flavoprotein-ubiquinone oxidoreductase, putative | 0.022 | 0.0792 | 1 |
Schistosoma mansoni | neuropeptide receptor | 0.0019 | 0.0027 | 0.0027 |
Mycobacterium leprae | PROBABLE D-AMINO ACID OXIDASE AAO | 0.2638 | 1 | 1 |
Echinococcus granulosus | Niemann Pick C1 protein | 0.016 | 0.0562 | 0.1756 |
Echinococcus multilocularis | neuropeptide receptor | 0.0143 | 0.0497 | 0.1591 |
Schistosoma mansoni | hypothetical protein | 0.0046 | 0.013 | 0.013 |
Echinococcus multilocularis | rhodopsin orphan GPCR | 0.0019 | 0.0027 | 0.0088 |
Echinococcus multilocularis | g protein linked acetylcholine receptor gar 2a | 0.0019 | 0.0027 | 0.0088 |
Schistosoma mansoni | rhodopsin-like orphan GPCR | 0.0019 | 0.0027 | 0.0027 |
Schistosoma mansoni | vesicular amine transporter | 0.0012 | 0.0002 | 0.0002 |
Brugia malayi | Dopamine receptor protein 1, putative (partial) | 0.0019 | 0.0027 | 0.0171 |
Echinococcus granulosus | glycerol 3 phosphate dehydrogenase | 0.022 | 0.0792 | 0.2474 |
Loa Loa (eye worm) | G-protein coupled receptor | 0.0019 | 0.0027 | 0.0025 |
Schistosoma mansoni | biogenic amine (dopamine) receptor | 0.0019 | 0.0027 | 0.0027 |
Echinococcus multilocularis | rhodopsin orphan GPCR | 0.0019 | 0.0027 | 0.0088 |
Echinococcus granulosus | G protein coupled 5 hydroxytryptamine receptor | 0.0019 | 0.0027 | 0.0086 |
Onchocerca volvulus | Dimethylglycine dehydrogenase, mitochondrial homolog | 0.022 | 0.0792 | 1 |
Echinococcus granulosus | rhodopsin orphan GPCR | 0.0019 | 0.0027 | 0.0086 |
Loa Loa (eye worm) | 5-hydroxytryptamine 2C receptor | 0.0019 | 0.0027 | 0.0025 |
Giardia lamblia | Glycerol-3-phosphate dehydrogenase | 0.022 | 0.0792 | 1 |
Echinococcus multilocularis | allatostatin A receptor | 0.0019 | 0.0027 | 0.0088 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0027 | 0.0171 |
Schistosoma mansoni | rhodopsin-like orphan GPCR | 0.0019 | 0.0027 | 0.0027 |
Schistosoma mansoni | biogenic amine receptor | 0.0019 | 0.0027 | 0.0027 |
Schistosoma mansoni | peptide (FMRFamide/neurokinin-3)-like receptor | 0.0019 | 0.0027 | 0.0027 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Echinococcus multilocularis | neuropeptide Y receptor | 0.0019 | 0.0027 | 0.0088 |
Brugia malayi | Niemann-Pick C1 protein precursor | 0.0112 | 0.038 | 0.2717 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0045 | 0.0124 | 0.0388 |
Echinococcus multilocularis | serotonin receptor | 0.0166 | 0.0587 | 0.1878 |
Loa Loa (eye worm) | neuropeptide F receptor | 0.0019 | 0.0027 | 0.0025 |
Trypanosoma cruzi | L-2-hydroxyglutarate dehydrogenase, mitochondrial, putative | 0.022 | 0.0792 | 1 |
Echinococcus granulosus | g protein coupled receptor | 0.0019 | 0.0027 | 0.0086 |
Echinococcus granulosus | biogenic amine 5HT receptor | 0.0019 | 0.0027 | 0.0086 |
Echinococcus granulosus | neuropeptide s receptor | 0.0019 | 0.0027 | 0.0086 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.0019 | 0.0027 | 0.0025 |
Trypanosoma cruzi | L-2-hydroxyglutarate dehydrogenase, mitochondrial, putative | 0.022 | 0.0792 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Brugia malayi | Dopamine receptor | 0.0019 | 0.0027 | 0.0171 |
Schistosoma mansoni | fad oxidoreductase | 0.022 | 0.0792 | 0.0792 |
Schistosoma mansoni | rhodopsin-like orphan GPCR | 0.0019 | 0.0027 | 0.0027 |
Loa Loa (eye worm) | unidentified vitellogenin-linked transcript protein 6 | 0.0019 | 0.0027 | 0.0025 |
Echinococcus multilocularis | neuropeptides capa receptor | 0.0019 | 0.0027 | 0.0088 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Brugia malayi | neuropeptide F receptor | 0.0019 | 0.0027 | 0.0171 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0021 | 0.0036 | 0.0232 |
Echinococcus granulosus | FAD dependent oxidoreductase domain containing protein | 0.022 | 0.0792 | 0.2474 |
Echinococcus multilocularis | g protein coupled receptor | 0.0019 | 0.0027 | 0.0088 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Loa Loa (eye worm) | hypothetical protein | 0.0059 | 0.0178 | 0.0175 |
Echinococcus granulosus | g-protein coupled receptor | 0.0019 | 0.0027 | 0.0086 |
Mycobacterium ulcerans | thiamine biosynthesis oxidoreductase ThiO | 0.022 | 0.0792 | 0.0759 |
Echinococcus multilocularis | expressed conserved protein | 0.0105 | 0.0354 | 0.1131 |
Echinococcus granulosus | 7TM GPCR rhodopsin | 0.0019 | 0.0027 | 0.0086 |
Schistosoma mansoni | opsin-like receptor | 0.0019 | 0.0027 | 0.0027 |
Brugia malayi | AKH receptor | 0.0019 | 0.0027 | 0.0171 |
Entamoeba histolytica | Niemann-Pick C1 protein, putative | 0.0112 | 0.038 | 0.4547 |
Trypanosoma brucei | L-2-hydroxyglutarate dehydrogenase, mitochondrial, putative | 0.022 | 0.0792 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Schistosoma mansoni | rhodopsin-like orphan GPCR | 0.0019 | 0.0027 | 0.0027 |
Echinococcus multilocularis | rhodopsin orphan GPCR | 0.0019 | 0.0027 | 0.0088 |
Schistosoma mansoni | ap endonuclease | 0.0021 | 0.0036 | 0.0036 |
Echinococcus granulosus | growth hormone secretagogue receptor type 1 | 0.0019 | 0.0027 | 0.0086 |
Echinococcus granulosus | somatostatin receptor | 0.0019 | 0.0027 | 0.0086 |
Echinococcus multilocularis | sex peptide receptor | 0.0019 | 0.0027 | 0.0088 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Echinococcus granulosus | dro:myosuppressin receptor | 0.0019 | 0.0027 | 0.0086 |
Schistosoma mansoni | thyrotropin-releasing hormone receptor | 0.0019 | 0.0027 | 0.0027 |
Schistosoma mansoni | amine GPCR | 0.0019 | 0.0027 | 0.0027 |
Brugia malayi | Raf kinase | 0.0215 | 0.0772 | 0.5552 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Schistosoma mansoni | biogenic amine (dopamine) receptor | 0.0019 | 0.0027 | 0.0027 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0013 | 0.0004 | 0.0004 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0027 | 0.0025 |
Echinococcus multilocularis | neuropeptides capa receptor | 0.0019 | 0.0027 | 0.0088 |
Echinococcus granulosus | expressed conserved protein | 0.0105 | 0.0354 | 0.1105 |
Echinococcus multilocularis | dro:myosuppressin receptor | 0.0019 | 0.0027 | 0.0088 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0021 | 0.0036 | 0.0114 |
Echinococcus multilocularis | serotonin receptor | 0.0166 | 0.0587 | 0.1878 |
Echinococcus granulosus | rhodopsin orphan GPCR | 0.0019 | 0.0027 | 0.0086 |
Mycobacterium tuberculosis | Possible thiamine biosynthesis oxidoreductase ThiO | 0.022 | 0.0792 | 0.0828 |
Echinococcus granulosus | rhodopsin orphan GPCR | 0.0019 | 0.0027 | 0.0086 |
Echinococcus multilocularis | 7TM GPCR, rhodopsin | 0.0019 | 0.0027 | 0.0088 |
Echinococcus multilocularis | fmrfamide receptor | 0.0019 | 0.0027 | 0.0088 |
Leishmania major | glycerol-3-phosphate dehydrogenase-like protein | 0.022 | 0.0792 | 1 |
Loa Loa (eye worm) | G-protein coupled receptor | 0.0019 | 0.0027 | 0.0025 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0027 | 0.0027 |
Echinococcus multilocularis | g protein coupled receptor | 0.0019 | 0.0027 | 0.0088 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0222 | 0.0801 | 0.0801 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Fu (ADMET) | = 3.2 % | Fraction unbound in human plasma by equilibrium dialysis method | ChEMBL. | 24215892 |
IC50 (functional) | = 12 nM | Antagonist activity at human orexin-2 receptor assessed as inhibition of orexin-A-induced intracellular calcium mobilization after 30 mins by cell-based FLIPR assay | ChEMBL. | 24215892 |
IC50 (functional) | = 292 nM | Antagonist activity at human orexin-1 receptor assessed as inhibition of orexin-A-induced intracellular calcium mobilization after 30 mins by cell-based FLIPR assay | ChEMBL. | 24215892 |
IC50 (binding) | = 1.04 uM | Inhibition of human 5-HT2B receptor | ChEMBL. | 24215892 |
IC50 (binding) | = 2.3 uM | Inhibition of human 5-HT1A receptor | ChEMBL. | 24215892 |
IC50 (binding) | = 2.4 uM | Inhibition of rat 5-HT1B receptor | ChEMBL. | 24215892 |
IC50 (binding) | = 5.02 uM | Inhibition of human mu opioid receptor | ChEMBL. | 24215892 |
IC50 (binding) | = 6.95 uM | Inhibition of human ERG | ChEMBL. | 24215892 |
IC50 (binding) | = 9.54 uM | Inhibition of human dopamine D3 receptor | ChEMBL. | 24215892 |
Inhibition (binding) | = -29 % | Inhibition of human MAPK14 at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -20 % | Inhibition of human NR1a/NR2a receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -19 % | Inhibition of human 5-HT2C receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -17 % | Inhibition of human NET at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -17 % | Inhibition of human COX-1 at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -16 % | Inhibition of human insulin receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -15 % | Inhibition of human SERT at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -14 % | Inhibition of human COX-2 at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -12 % | Inhibition of human AChE at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -11 % | Inhibition of human histamine H2 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -10 % | Inhibition of human CGRP1 at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -10 % | Inhibition of human bradykinin B2 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -10 % | Inhibition of human ECE-1 at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -8 % | Inhibition of human 5-HT6 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -8 % | Inhibition of human muscarinic M2 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -8 % | Inhibition of human PDE5 at 100 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -8 % | Inhibition of human cathepsin G at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -7 % | Inhibition of human DAT at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -7 % | Inhibition of human ERbeta receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -6 % | Inhibition of human MMP-12 at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -5 % | Inhibition of rat insulin receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -5 % | Inhibition of human SRC at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -5 % | Inhibition of human neutral endopeptidase at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -4 % | Inhibition of rat 5-HT1B receptor at 10 nM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -4 % | Inhibition of human CCKB receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -3 % | Inhibition of rat TRH receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -3 % | Inhibition of human SST2 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -3 % | Inhibition of human 5-HT3 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -3 % | Inhibition of human mu opioid receptor at 10 nM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -3 % | Inhibition of human mu opioid receptor at 0.1 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -3 % | Inhibition of human histamine H3 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -3 % | Inhibition of rat tyrosine hydroxylase at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -2 % | Inhibition of human prostanoid IP receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -2 % | Inhibition of human muscarinic M3 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -2 % | Inhibition of human dopamine D2S receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -2 % | Inhibition of human neutrophil elastase 2 at 30 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -1 % | Inhibition of human CD45 at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -1 % | Inhibition of human caspase 8 at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -1 % | Inhibition of human caspase 3 at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = -1 % | Inhibition of rat nNOS at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 0 % | Inhibition of human V2 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 0 % | Inhibition of human V1A receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 0 % | Inhibition of human neuropeptide YY2 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 0 % | Inhibition of human muscarinic M1 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 0 % | Inhibition of rat IP3 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 0 % | Inhibition of human CXCR2 at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 0 % | Inhibition of human PDE3 at 100 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 1 % | Inhibition of human muscarinic M5 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 1 % | Inhibition of guinea pig atrial natriuretic factor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 1 % | Inhibition of human PTP1B at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 1 % | Inhibition of human caspase 7 at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 1 % | Inhibition of rat NMDA receptor agonist binding site at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 2 % | Inhibition of human 5-HT1A receptor at 10 nM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 2 % | Inhibition of human MC3 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 2 % | Inhibition of human dopamine D1 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 2 % | Inhibition of human CB2 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 2 % | Inhibition of mouse iNOS at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 3 % | Inhibition of human PPARgamma at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 3 % | Inhibition of human ERG at 10 nM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 3 % | Inhibition of human GAL1 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 3 % | Inhibition of human dopamine D5 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 3 % | Inhibition of human dopamine D4.4 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 3 % | Inhibition of human dopamine D3 receptor at 0.1 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 3 % | Inhibition of human bradykinin B1 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 4 % | Inhibition of human ETA receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 4 % | Inhibition of human TCPTP at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 4 % | Inhibition of human PDE2 at 100 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 4 % | Inhibition of human MMP-1 at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 4 % | Inhibition of human caspase 1 at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 5 % | Inhibition of human SST4 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 5 % | Inhibition of human PPARalpha at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 5 % | Inhibition of human dopamine D3 receptor at 10 nM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 5 % | Inhibition of human alpha2C adrenergic receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 5 % | Inhibition of human PDE4 at 100 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 5 % | Inhibition of rat NMDA receptor phencyclidine binding site at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 6 % | Inhibition of human VIP1 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 6 % | Inhibition of human 5-HT2B receptor at 10 nM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 6 % | Inhibition of human 5-HT2B receptor at 0.1 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 6 % | Inhibition of human MC4 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 6 % | Inhibition of human GAL2 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 7 % | Inhibition of human muscarinic M4 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 7 % | Inhibition of human EGF at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 7 % | Inhibition of rat androgen receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 7 % | Inhibition of human caspase 6 at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 8 % | Inhibition of human delta opioid receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 8 % | Inhibition of human ETB receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 8 % | Inhibition of human adenosine A2A receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 9 % | Inhibition of rat 5-HT1B receptor at 0.1 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 9 % | Inhibition of rat potassium channel [SKCA] at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 9 % | Inhibition of human ORL1 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 9 % | Inhibition of human kappa opioid receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 9 % | Inhibition of human MC5 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 9 % | Inhibition of human CysLT1 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 9 % | Inhibition of human histamine H4 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 9 % | Inhibition of human CCKA receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 9 % | Inhibition of human calcitonin receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 9 % | Inhibition of human beta1 adrenergic receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 9 % | Inhibition of rat NMDA receptor glycine binding site at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 10 % | Inhibition of human 5-HT1A receptor at 0.1 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 10 % | Inhibition of human prostanoid EP1 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 10 % | Inhibition of human histamine H1 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 10 % | Inhibition of human CB1 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 10 % | Inhibition of human EGF receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 10 % | Inhibition of human MAPK3 at 100 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 11 % | Inhibition of human CCR5 at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 11 % | Inhibition of human 12-lipoxygenase at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 12 % | Inhibition of human ERG at 0.1 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 13 % | Inhibition of human NK3 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 14 % | Inhibition of human SST5 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 14 % | Inhibition of human SST1 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 14 % | Inhibition of human oxytocin receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 14 % | Inhibition of human GABA alpha5beta3gamma2 receptor muscimol binding site at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 14 % | Inhibition of human angiotensin AT1 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 16 % | Inhibition of human prostanoid DP receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 17 % | Inhibition of human thromboxane A2 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 17 % | Inhibition of human ERG at 1 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 18 % | Inhibition of human GABA alpha5beta3gamma2 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 18 % | Inhibition of human angiotensin AT2 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 19 % | Inhibition of human prostanoid FP receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 19 % | Inhibition of human prostanoid EP4 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 19 % | Inhibition of human prostanoid EP3 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 19 % | Inhibition of human dopamine D3 receptor at 1 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 19 % | Inhibition of human alpha2A adrenergic receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 20 % | Inhibition of human ERalpha receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 20 % | Inhibition of human FLT1 at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 21 % | Inhibition of human NT1 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 21 % | Inhibition of human GABA alpha1beta3gamma2 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 21 % | Inhibition of human CCR1 at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 22 % | Inhibition of guinea pig 5-HT4 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 22 % | Inhibition of human adenosine A1 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 23 % | Inhibition of human neuropeptide YY1 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 23 % | Inhibition of human beta2 adrenergic receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 24 % | Inhibition of human beta3 adrenergic receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 25 % | Inhibition of human NK2 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 26 % | Inhibition of human NK1 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 26 % | Inhibition of human mu opioid receptor at 1 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 26 % | Inhibition of human alpha1D adrenergic receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 29 % | Inhibition of human PRKCA at 100 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 30 % | Inhibition of human SST3 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 30 % | Inhibition of rat 5-HT1B receptor at 1 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 31 % | Inhibition of human PAF receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 31 % | Inhibition of human MAO-B at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 33 % | Inhibition of human adenosine A3 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 34 % | Inhibition of human alpha2B adrenergic receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 39 % | Inhibition of human GABA alpha1beta3gamma2 receptor muscimol binding site at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 41 % | Inhibition of human 5-HT1A receptor at 1 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 41 % | Inhibition of human MAO-A at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 44 % | Inhibition of human 5-lipoxygenase at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 51 % | Inhibition of human dopamine D3 receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 52 % | Inhibition of human 5-HT2B receptor at 1 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 58 % | Inhibition of human ERG at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 62 % | Inhibition of human mu opioid receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 69 % | Inhibition of human 5-HT1A receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 73 % | Inhibition of rat 5-HT1B receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Inhibition (binding) | = 84 % | Inhibition of human 5-HT2B receptor at 10 uM relative to control | ChEMBL. | 24215892 |
Ki (binding) | = 0.07 nM | Displacement of [3H]SB-674042 from human orexin-2 receptor after 60 mins by scintillation counting analysis | ChEMBL. | 24215892 |
Ki (binding) | = 94.5 nM | Displacement of [3H]SB-674042 from human orexin-1 receptor after 60 mins by scintillation counting analysis | ChEMBL. | 24215892 |
Ki (binding) | = 0.662 uM | Inhibition of human 5-HT2B receptor | ChEMBL. | 24215892 |
Ki (binding) | = 1.31 uM | Inhibition of human 5-HT1A receptor | ChEMBL. | 24215892 |
Ki (binding) | = 2.04 uM | Inhibition of human mu opioid receptor | ChEMBL. | 24215892 |
Ki (binding) | = 2.28 uM | Inhibition of rat 5-HT1B receptor | ChEMBL. | 24215892 |
Ki (binding) | = 3.24 uM | Inhibition of human dopamine D3 receptor | ChEMBL. | 24215892 |
Ratio (ADMET) | = 6.4 | Activity at human MDR1 expressed in pig LLC-PK cells assessed as efflux ratio of permeability from basolateral to apical side over apical to basolateral side | ChEMBL. | 24215892 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.